- Open
- 26.30
- High
- 26.30
- Low
- 25.30
- Close
- 25.30
- Change
- -0.40 (-1.56%)
- Volume
- 25,113
| 27 Jul 2026 | 07:00:06 | Share Buyback |
| 17 Jul 2026 | 10:19:50 | Share Buyback |
| 16 Jul 2026 | 07:00:02 | Share Buyback |
| 15 Jul 2026 | 07:00:04 | Share Buyback |
| 15 Jun 2026 | 12:36:55 | Share Buyback |
| 24 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) |
EKF is a prominent manufacturer of point-of-care diagnostics and central laboratory assays, with a global presence in over 100 countries. Their range of products includes hemoglobin, hematocrit, HbA1c, glucose, and lactate analyzers, with an estimated 80,000 units in use worldwide.
Lord Howard of Rising has interests in this issuer
| 27 Jul 2026 | 07:00:06 | Share Buyback |
| 17 Jul 2026 | 10:19:50 | Share Buyback |
| 16 Jul 2026 | 07:00:02 | Share Buyback |
| 15 Jul 2026 | 07:00:04 | Share Buyback |
| 15 Jun 2026 | 12:36:55 | Share Buyback |
| 24 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) |
EKF is a prominent manufacturer of point-of-care diagnostics and central laboratory assays, with a global presence in over 100 countries. Their range of products includes hemoglobin, hematocrit, HbA1c, glucose, and lactate analyzers, with an estimated 80,000 units in use worldwide.
Lord Howard of Rising has interests in this issuer
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £200.73bn | +0.2% | |
| £615m | +0.3% | |
| £326m | -0.3% | |
| £319m | +0.7% | |
| £230m | +0.3% | |
EKFEKF Diagnostics Holdings PLC | — | -0.0% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £200.73bn | +0.2% | |
| £615m | +0.3% | |
| £326m | -0.3% | |
| £319m | +0.7% | |
| £230m | +0.3% | |
EKFEKF Diagnostics Holdings PLC | — | -0.0% |
